104 related articles for article (PubMed ID: 8823265)
1. Cisplatin and low dose rate irradiation in cisplatin resistant and sensitive human glioma cells.
Wilkins DE; Ng CE; Raaphorst GP
Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):105-11. PubMed ID: 8823265
[TBL] [Abstract][Full Text] [Related]
2. Concomitant treatment with mild hyperthermia, cisplatin and low dose-rate irradiation in human ovarian cancer cells sensitive and resistant to cisplatin.
Raaphorst GP; Maio J; Ng CE; Stewart DJ
Oncol Rep; 1998; 5(4):971-7. PubMed ID: 9625857
[TBL] [Abstract][Full Text] [Related]
3. Concomitant low dose-rate irradiation and cisplatin treatment in ovarian carcinoma cell lines sensitive and resistant to cisplatin treatment.
Raaphorst GP; Wang G; Stewart D; Ng CE
Int J Radiat Biol; 1996 May; 69(5):623-31. PubMed ID: 8648250
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin and mild hyperthermia in radiosensitization to low dose rate irradiation in human ovarian carcinoma cells.
Raaphorst GP; Miao J; Ng CE
Anticancer Res; 1997; 17(5A):3469-72. PubMed ID: 9413189
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin, hyperthermia and radiation treatment in human cisplatin-sensitive and resistant glioma cell lines.
Raaphorst GP; Yang H; Wilkins DE; Ng CE
Int J Hyperthermia; 1996; 12(6):801-12. PubMed ID: 8950160
[TBL] [Abstract][Full Text] [Related]
6. Thermal radiosensitization by 41 degrees C hyperthermia during low dose-rate irradiation in human normal and tumour cell lines.
Raaphorst GP; Heller DP; Bussey A; Ng CE
Int J Hyperthermia; 1994; 10(2):263-70. PubMed ID: 8064184
[TBL] [Abstract][Full Text] [Related]
7. Cell cycle perturbations in cisplatin-sensitive and resistant human ovarian carcinoma cells following treatment with cisplatin and low dose rate irradiation.
Wilkins DE; Ng CE; Raaphorst GP
Cancer Chemother Pharmacol; 1997; 40(2):159-66. PubMed ID: 9182838
[TBL] [Abstract][Full Text] [Related]
8. A comparison of hyperthermia cisplatin sensitization in human ovarian carcinoma and glioma cell lines sensitive and resistant to cisplatin treatment.
Raaphorst GP; Doja S; Davis L; Stewart D; Ng CE
Cancer Chemother Pharmacol; 1996; 37(6):574-80. PubMed ID: 8612312
[TBL] [Abstract][Full Text] [Related]
9. Low dose rate irradiation and halogenated pyrimidine effects on human cervical carcinoma cells.
Tishler RB; Geard CR
Int J Radiat Oncol Biol Phys; 1991 Sep; 21(4):975-82. PubMed ID: 1917628
[TBL] [Abstract][Full Text] [Related]
10. Equivalence of pulsed-dose-rate to low-dose-rate irradiation in tumor and normal cell lines.
Niedbala M; Alsbeih G; Ng CE; Raaphorst GP
Radiat Res; 2001 Feb; 155(2):297-303. PubMed ID: 11175664
[TBL] [Abstract][Full Text] [Related]
11. The biological effect of pentoxifylline on the survival of human head and neck cancer cells treated with continuous low and high dose-rate irradiation.
Danielsson A; Karlsson E; Delle U; Helou K; Mercke C
J Cancer Res Clin Oncol; 2005 Jul; 131(7):459-67. PubMed ID: 15776273
[TBL] [Abstract][Full Text] [Related]
12. Combined gamma-irradiation and subsequent cisplatin treatment in human squamous carcinoma cell lines sensitive and resistant to cisplatin.
Caney C; Singh G; Lukka H; Rainbow AJ
Int J Radiat Biol; 2004 Apr; 80(4):291-9. PubMed ID: 15204706
[TBL] [Abstract][Full Text] [Related]
13. Interaction between low dose-rate irradiation, mild hyperthermia and low-dose caffeine in a human lung cancer cell line.
Sakurai H; Mitsuhashi N; Tamaki Y; Akimoto T; Murata O; Kitamoto Y; Maebayashi K; Ishikawa H; Hayakawa K; Niibe H
Int J Radiat Biol; 1999 Jun; 75(6):739-45. PubMed ID: 10405004
[TBL] [Abstract][Full Text] [Related]
14. Interactions of mild hyperthermia, cisplatin and split dose irradiation in human ovarian carcinoma cells.
Raaphorst GP; Miao J; Stewart D; Ng CE
Cancer Chemother Pharmacol; 1998; 41(6):491-6. PubMed ID: 9554594
[TBL] [Abstract][Full Text] [Related]
15. Overview of radiosensitivity of human tumor cells to low-dose-rate irradiation.
Williams JR; Zhang Y; Zhou H; Gridley DS; Koch CJ; Slater JM; Little JB
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):909-17. PubMed ID: 19014780
[TBL] [Abstract][Full Text] [Related]
16. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.
Ning S; Trisler K; Wessels BW; Knox SJ
Cancer; 1997 Dec; 80(12 Suppl):2519-28. PubMed ID: 9406705
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the combined action of oxaliplatin or cisplatin and radiation in cervical and lung cancer cells.
Rave-Fränk M; Schmidberger H; Christiansen H; Boll C; Lehmann J; Weiss E
Int J Radiat Biol; 2007 Jan; 83(1):41-7. PubMed ID: 17357438
[TBL] [Abstract][Full Text] [Related]
18. Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines.
Groen HJ; Sleijfer S; Meijer C; Kampinga HH; Konings AW; De Vries EG; Mulder NH
Br J Cancer; 1995 Dec; 72(6):1406-11. PubMed ID: 8519652
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic enhancement of low dose-rate irradiation in human lung cancer cells by mild hyperthermia.
Sakurai H; Mitsuhashi N; Kitamoto Y; Nonaka T; Harashima K; Higuchi K; Muramatsu H; Ebara T; Ishikawa H; Niibe H
Anticancer Res; 1998; 18(4A):2525-8. PubMed ID: 9703904
[TBL] [Abstract][Full Text] [Related]
20. Enhanced DNA repair and tolerance of DNA damage associated with resistance to cis-diammine-dichloroplatinum (II) after in vitro exposure of a human teratoma cell line to fractionated X-irradiation.
Hill BT; Shellard SA; Hosking LK; Fichtinger-Schepman AM; Bedford P
Int J Radiat Oncol Biol Phys; 1990 Jul; 19(1):75-83. PubMed ID: 2380098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
